Lifecore Biomedical 

$4.78
0
+$0.15+3.24% Tuesday 04:00

Statistics

Day High
4.78
Day Low
4.63
52W High
-
52W Low
-
Volume
330
Avg. Volume
-
Mkt Cap
179.09M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q4 0
Q2 2025
Q4 2025
Next
-0.29
-0.21
-0.14
-0.06
Expected EPS
-0.29
Actual EPS
N/A

Financials

-34.42%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
257.73MRevenue
-88.72MNet Income

Analyst Ratings

6Average Price Target
The highest estimate is 6.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LFCR.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zimmer Biomet
ZBH
Mkt Cap17.67B
Zimmer Biomet Holdings, Inc. competes in the development, manufacturing, and marketing of orthopedic reconstructive products, a sector where Lifecore Biomedical also operates, particularly in biomaterials.
Stryker
SYK
Mkt Cap125.43B
Stryker Corporation is a direct competitor in the medical technology and orthopedics sector, offering products that overlap with Lifecore Biomedical's offerings in surgical and medical instruments.
Boston Scientific
BSX
Mkt Cap92.25B
Boston Scientific Corporation competes with Lifecore Biomedical in the medical devices sector, focusing on products for interventional medical specialties, including areas where Lifecore's biomaterials could be applied.
Medtronic
MDT
Mkt Cap106.97B
Medtronic plc operates in the global healthcare technology space, offering products that compete with Lifecore Biomedical in areas such as surgical solutions and patient monitoring.
Johnson & Johnson
JNJ
Mkt Cap547.64B
Johnson & Johnson operates in the healthcare field with a broad range of products that compete with Lifecore Biomedical, especially in the surgical products and medical devices segments.
Abbott Laboratories
ABT
Mkt Cap158.36B
Abbott Laboratories offers medical devices, diagnostics, and nutritional products that compete with Lifecore Biomedical's range of healthcare solutions and biomaterials.
Baxter International
BAX
Mkt Cap9.38B
Baxter International Inc. provides a broad array of medical devices and pharmaceuticals that compete with Lifecore Biomedical in the medical supplies and biotechnology sectors.
Edwards Lifesciences
EW
Mkt Cap48.52B
Edwards Lifesciences Corporation specializes in heart valves and hemodynamic monitoring, competing with Lifecore Biomedical in the cardiovascular and surgical products markets.
Intuitive Surgical
ISRG
Mkt Cap170.78B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, competing with Lifecore Biomedical in the advanced surgical instruments and medical devices sector.
Hologic
HOLX
Mkt Cap16.97B
Hologic, Inc. focuses on diagnostics, medical imaging systems, and surgical products, particularly in women's health, where it competes with Lifecore Biomedical's medical technology and biomaterials.

About

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Show more...
CEO
ISIN
US5147661046

Listings

0 Comments

Share your thoughts

FAQ

What is Lifecore Biomedical stock price today?
The current price of LFCR.BOATS is $4.78 USD — it has increased by +3.24% in the past 24 hours. Watch Lifecore Biomedical stock price performance more closely on the chart.
What is Lifecore Biomedical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lifecore Biomedical stocks are traded under the ticker LFCR.BOATS.
What is Lifecore Biomedical market cap?
Today Lifecore Biomedical has the market capitalization of 179.09M
When is the next Lifecore Biomedical earnings date?
Lifecore Biomedical is going to release the next earnings report on August 06, 2026.
What were Lifecore Biomedical earnings last quarter?
LFCR.BOATS earnings for the last quarter are -0.16 USD per share, whereas the estimation was -0.29 USD resulting in a +44.83% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lifecore Biomedical revenue for the last year?
Lifecore Biomedical revenue for the last year amounts to 257.73M USD.
What is Lifecore Biomedical net income for the last year?
LFCR.BOATS net income for the last year is -88.72M USD.
In which sector is Lifecore Biomedical located?
Lifecore Biomedical operates in the Other sector.
When did Lifecore Biomedical complete a stock split?
Lifecore Biomedical has not had any recent stock splits.